Parma Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Parma
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Parma News
Permeable inspection of pharmaceuticals: Real-time tablet quality inspection system developed
Led by Assistant Professor Kou Li, a research group at Chuo University, Japan, has developed a synergetic strategy among non-destructive terahertz (THz)–infrared (IR) photo-monitoring techniques and ...
Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disorders
Mankind Pharma on Monday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial for a molecule under development for the ...
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said it hopes this will help improve ...
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...

